Compare Cipher Mining Inc (CIFR) vs Heron Therapeutics Inc (HRTX) Price & Performance

CIFR trades at $17.74, up 8.63% in the last session, but remains in a bearish technical trend with key support at $16. The company is transitioning from Bitcoin mining to AI data centers, reporting a Q2 2026 loss per share of $0.65, missing estimates. Revenue was $224 million in 2025 but fell to $191 million in 2026, with a net loss widening to $1.1 billion. Despite negative profitability metrics, analyst consensus is unanimously bullish with a $31.78 price target.

The outlook hinges on successful execution of its AI infrastructure pivot, offering growth potential but carrying high risk due to persistent losses, heavy capital expenditure, and reliance on project financing. Investors face volatility from operational cash burn and competitive pressures in the data center market, warranting caution despite optimistic Wall Street ratings.

HRTX trades at $0.3507, up 6.21% in the last 24 hours, but technical indicators signal a bearish trend overall. The company reported Q2 2026 revenue of $37.7 million, missing estimates, with a net loss per share of $0.03. Despite a high gross profit margin of 70.07%, negative net income and cash flow from operations highlight financial strain. Analyst consensus remains strongly bullish with 94.74% buy ratings, but recent news includes a Zacks Strong Sell designation on July 15, 2026.

The outlook is mixed: strong analyst support contrasts with weak earnings and bearish technicals. Investment opportunity lies in potential turnaround if revenue growth accelerates, but risks include persistent losses, competitive pressures, and reliance on financing activities. The stock faces significant downside if operational performance does not improve.